1-20 of 32
Section: Embryonal Tumors
Save search
Sort by
Journal Article

EMBR-15. PRC2 COMPLEX ENFORCES NEURONAL LINEAGE AND SUPPRESSES TUMOR GROWTH IN SHH MEDULLOBLASTOMA Open Access

PDF
Abigail Cleveland and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Pages i8–i9, https://doi.org/10.1093/neuonc/noab090.033
Published: 01 June 2021
Journal Article

EMBR-04. BET INHIBITION TARGETS RADIOTHERAPY RESISTANCE IN H3K27ME3-DEFICIENT GROUP 3 MEDULLOBLASTOMA Open Access

PDF
Nishanth Gabriel and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i6, https://doi.org/10.1093/neuonc/noab090.022
Published: 01 June 2021
Journal Article

EMBR-25. GENOME-WIDE GENETIC AND EPIGENETIC ASSESSMENT OF GROUP 4 MEDULLOBLASTOMA FOR IMPROVED, BIOMARKER DRIVEN, PROGNOSTICATION AND RISK-STRATIFICATION Open Access

PDF
Jack Goddard and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i11, https://doi.org/10.1093/neuonc/noab090.043
Published: 01 June 2021
Journal Article

EMBR-24. YB1 IS CRITICAL FOR MEDULLOBLASTOMA TUMOR MAINTENANCE AND DNA REPAIR FOLLOWING THERAPEUTIC INTERVENTION Open Access

PDF
Leon McSwain and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i11, https://doi.org/10.1093/neuonc/noab090.042
Published: 01 June 2021
Journal Article

EMBR-07. MYC BUT NOT MYCN GENERATES AGGRESSIVE GROUP 3 MEDULLOBLASTOMA BY ARF PATHWAY SUPPRESSION Open Access

PDF
Oliver Mainwaring and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i7, https://doi.org/10.1093/neuonc/noab090.025
Published: 01 June 2021
Journal Article

EMBR-14. INFLUENCE OF MRI FEATURES ON THE SURVIVAL AND IMPACT ON INDIVIDUAL MOLECULAR SUBGROUPS: RESULT FROM 171 PATIENTS WITH MEDULLOBLASTOMA Open Access

PDF
Archya Dasgupta and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i8, https://doi.org/10.1093/neuonc/noab090.032
Published: 01 June 2021
Journal Article

EMBR-29. PEDIATRIC MEDULLOBLASTOMA PATIENT WITH MULTIPLE MIDLINE DEFECTS, A CASE REPORT Open Access

PDF
Sydney Peck and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i12, https://doi.org/10.1093/neuonc/noab090.046
Published: 01 June 2021
Journal Article

EMBR-17. DE-INTENSIFICATION OF RADIOTHERAPY IN RIGOROUSLY DEFINED LOW-RISK WNT-SUBGROUP MEDULLOBLASTOMA IS ASSOCIATED WITH UNACCEPTABLY HIGH RISK OF NEURAXIAL FAILURE: RESULTS FROM THE PROSPECTIVE FOR-WNT STUDY Open Access

PDF
Tejpal Gupta and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i9, https://doi.org/10.1093/neuonc/noab090.035
Published: 01 June 2021
Journal Article

EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA Open Access

PDF
Jordan Hansford and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i6, https://doi.org/10.1093/neuonc/noab090.021
Published: 01 June 2021
Journal Article

EMBR-10. INOSITOL TREATMENT INHIBITS MEDULLOBLASTOMA THROUGH SUPPRESSION OF EPIGENETIC-DRIVEN METABOLIC ADAPTATION Open Access

PDF
Sara Badodi and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i7, https://doi.org/10.1093/neuonc/noab090.028
Published: 01 June 2021
Journal Article

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA Open Access

PDF
Gintvile Valinciute and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i5, https://doi.org/10.1093/neuonc/noab090.019
Published: 01 June 2021
Journal Article

EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA Open Access

PDF
Vikas Daggubati and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i9, https://doi.org/10.1093/neuonc/noab090.034
Published: 01 June 2021
Journal Article

EMBR-08. CORRELATION OF HISTOPATHOLOGY, CHROMOSOMAL MICROARRAY, AND NANOSTRING BASED 22-GENE ASSAY FOR MEDULLOBLASTOMA SUBGROUP ASSIGNMENT ON “HEAD START” 4 CLINICAL TRIAL Open Access

PDF
Girish Dhall and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i7, https://doi.org/10.1093/neuonc/noab090.026
Published: 01 June 2021
Journal Article

EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA Open Access

PDF
David Bakhshinyan and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i10, https://doi.org/10.1093/neuonc/noab090.040
Published: 01 June 2021
Journal Article

EMBR-30. A NOVEL PLK1 INHIBITOR ONVANSERTIB EFFECTIVELY SENSITIZES GROUP 3 MEDULLOBLASTOMA TO RADIOTHERAPY Open Access

PDF
Dong Wang and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i12, https://doi.org/10.1093/neuonc/noab090.047
Published: 01 June 2021
Journal Article

EMBR-05. THE TENTATIVE APPLICATION OF EN BLOC CONCEPT IN THE PEDIATRIC BRAIN TUMOR: EXPERIENCE FROM A LARGE PEDIATRIC CENTER IN CHINA Open Access

PDF
Liangliang Cao and Jie Ma
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i6, https://doi.org/10.1093/neuonc/noab090.023
Published: 01 June 2021
Journal Article

EMBR-13. NOVEL SYNERGISTIC APPROACHES FOR TARGETED THERAPY OF MYC-DRIVEN MEDULLOBLASTOMA USING CRISPR/CAS9 GENE EDITING Open Access

PDF
Nan Qin and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i8, https://doi.org/10.1093/neuonc/noab090.031
Published: 01 June 2021
Journal Article

EMBR-12. TARGETING THE RNA-BINDING PROTEIN LIN28B IN GROUP 3 MEDULLOBLASTOMA Open Access

PDF
Shubin Shahab and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i8, https://doi.org/10.1093/neuonc/noab090.030
Published: 01 June 2021
Journal Article

EMBR-28. CNS DISTRIBUTIONAL KINETICS OF PANOBINOSTAT IN THE MOUSE Open Access

PDF
Wenqiu Zhang and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i12, https://doi.org/10.1093/neuonc/noab090.045
Published: 01 June 2021
Journal Article

EMBR-02. OLIG2 REPRESENTS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN MYC-AMPLIFIED MEDULLOBLASTOMA RELAPSE AND METASTASIS Open Access

PDF
Zhenhua Xu and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Pages i5–i6, https://doi.org/10.1093/neuonc/noab090.020
Published: 01 June 2021